Search

In Stock

Buy Tremfya (guselkumab) Online

DISEASE INDICATIONS: Psoriasis

MANUFACTURER: Janssen Biotech

USAGE: Subcutaneous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Pharmaceuticals and Medical Devices Agency (PMDA)

Therapeutic Goods Administration (TGA)

Tremfya is a pharmaceutical medication that contains the active ingredient guselkumab. It belongs to a class of medications known as interleukin-23 (IL-23) inhibitors and is primarily used in the treatment of certain chronic skin conditions, particularly moderate to severe plaque psoriasis. Guselkumab works by targeting specific proteins in the immune system that play a role in the development of psoriatic skin lesions, thereby reducing the symptoms associated with this condition.

$2,860.64

Clear
Compare

Tremfya is a pharmaceutical medication that contains the active ingredient guselkumab. It belongs to a class of medications known as interleukin-23 (IL-23) inhibitors and is primarily used in the treatment of certain chronic skin conditions, particularly moderate to severe plaque psoriasis. Guselkumab works by targeting specific proteins in the immune system that play a role in the development of psoriatic skin lesions, thereby reducing the symptoms associated with this condition.

Here is a detailed description of Tremfya:

Active Ingredient:

  • Guselkumab: Guselkumab is an interleukin-23 (IL-23) inhibitor. It specifically targets and inhibits the action of IL-23, a cytokine that is involved in the inflammatory response associated with conditions like psoriasis. By blocking IL-23, guselkumab helps to reduce inflammation and the formation of psoriatic plaques on the skin.

Indications:

Tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy. Plaque psoriasis is a chronic skin condition characterized by the presence of raised, red, and scaly skin lesions.

Usage:

The dosing and administration of Tremfya are typically determined by a healthcare provider. It is administered as a subcutaneous injection, which means it is injected just below the skin. The frequency and duration of treatment can vary based on the individual patient’s response to therapy.

Mechanism of Action:

Guselkumab, the active ingredient in Tremfya, works by specifically inhibiting the action of IL-23. IL-23 is known to play a significant role in the inflammatory process and the development of psoriatic skin lesions. By blocking IL-23, guselkumab helps to reduce inflammation and the formation of psoriatic plaques, leading to symptom relief.

Benefits:

Tremfya offers the benefit of effectively managing moderate to severe plaque psoriasis, a condition that can be physically and emotionally challenging for affected individuals. It can help reduce the extent of skin involvement, alleviate itching, and improve the overall quality of life.

Precautions:

Before starting Tremfya, patients should undergo a thorough evaluation by a healthcare provider. It is important to inform the healthcare provider of any allergies, medical conditions, or other medications being taken, as these factors can affect the safety and efficacy of the medication.

Side Effects:

Common side effects of Tremfya may include upper respiratory tract infections, headache, and injection site reactions. Patients may also be at a slightly increased risk of infections while taking Tremfya. Patients should discuss any side effects or concerns with their healthcare provider.

In conclusion, Tremfya (guselkumab) is a medication used to treat moderate to severe plaque psoriasis in adult patients. It works by specifically inhibiting IL-23, a key player in the inflammatory process associated with psoriasis. Patients should use it as directed by their healthcare provider and be aware of potential side effects and precautions associated with its use.

Package

100 mg/ml guselkumab

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Tremfya (guselkumab) Online

$2,860.64
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Janssen Biotech USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA) Tremfya is a pharmaceutical medication that contains the active ingredient guselkumab. It belongs to a class of medications known as interleukin-23 (IL-23) inhibitors and is primarily used in the treatment of certain chronic skin conditions, particularly moderate to severe plaque psoriasis. Guselkumab works by targeting specific proteins in the immune system that play a role in the development of psoriatic skin lesions, thereby reducing the symptoms associated with this condition.

Buy Rinvoq (upadacitinib) Online

$1,955.31
(0 Reviews)
Rinvoq is a pharmaceutical medication that contains the active ingredient upadacitinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used to treat autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Upadacitinib works by targeting specific enzymes in the immune system, helping to reduce inflammation and alleviate the symptoms associated with these conditions.

Buy Taltz (ixekizumab) Online

From $2,499.58
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.

Buy Olumiant (baricitinib) Online

From $1,070.33
(0 Reviews)
DISEASE INDICATIONS: Rheumatoid Arthritis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Olumiant (baricitinib) is a prescription medication used to treat rheumatoid arthritis (RA), alopecia areata, and COVID-19. It is a Janus kinase (JAK) inhibitor, which means that it blocks the activity of JAK enzymes. JAK enzymes are involved in the signaling pathway that leads to inflammation.

Buy Tymlos (abaloparatide) Online

$2,636.72
(0 Reviews)
DISEASE INDICATIONS: Osteoporosis MANUFACTURER: Radius Health, Inc. USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Tymlos is a prescription medication used to treat osteoporosis, a condition characterized by the weakening of bones, which can lead to an increased risk of fractures and bone fractures. It is specifically indicated for postmenopausal women at high risk of fracture or those who have failed other osteoporosis treatments.

Buy Truxima (rituximab) Online

From $623.55
(0 Reviews)
DISEASE INDICATIONS: Leukemia, Lymphoma, Rheumatoid Arthritis, Granulomatosis, Polyangiitis MANUFACTURER: Celltrion Healthcare Hungary Kft / Teva Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Medsafe (NZ) Truxima (rituximab) is a drug employed in the management of various medical conditions, including follicular lymphoma and diffuse large B-cell Non-Hodgkin’s Lymphoma (NHL), chronic lymphocytic leukemia (CLL), severe active rheumatoid arthritis, as well as granulomatosis with polyangiitis and microscopic polyangiitis.

Buy Jyseleca (filgotinib) Online

From $1,239.61
(0 Reviews)
DISEASE INDICATIONS: Rheumatoid Arthritis MANUFACTURER: Galapagos USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Pharmaceuticals and Medical Devices Agency (PMDA)   Jyseleca is a pharmaceutical medication that contains the active ingredient filgotinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used in the treatment of various autoimmune diseases, including rheumatoid arthritis. Filgotinib works by targeting specific enzymes involved in the inflammatory process, helping to reduce inflammation and manage the symptoms of these conditions.

Back to Top
Product has been added to your cart